T1	Drug	10	19	donepezil	DrugBank:DB00843	Donepezil
T29	Disease	28	53	dementia with Lewy bodies	UMLS:C0752347	Lewy Body Disease
T2	Drug	148	157	donepezil	DrugBank:DB00843	Donepezil
T30	Disease	181	212	dementia with Lewy bodies (DLB)	UMLS:C0752347	Lewy Body Disease
T31	Disease	383	386	DLB	UMLS:C0752347	Lewy Body Disease
T63	Measure	776	812	Mini-Mental State Examination (MMSE)	UMLS:C0451306	Mini-mental state examination
T64	Measure	840	872	Neuropsychiatric Inventory (NPI)	UMLS:C3539727	Neuropsychiatric Inventory Questionnaire
T65	Phenotype	877	896	behavioral symptoms	UMLS:C0004941	Behavioral Symptoms
T66	Measure	1098	1102	MMSE	UMLS:C0451306	Mini-mental state examination
T67	Measure	1297	1300	NPI	UMLS:C3539727	Neuropsychiatric Inventory Questionnaire
T3	Drug	1686	1695	donepezil	DrugBank:DB00843	Donepezil
T32	Disease	1773	1776	DLB	UMLS:C0752347	Lewy Body Disease
T33	Disease	2042	2073	Dementia with Lewy bodies (DLB)	UMLS:C0752347	Lewy Body Disease
T53	Disease	2094	2102	dementia	UMLS:C0497327	Dementia
T54	Disease	2177	2185	dementia	UMLS:C0497327	Dementia
T62	Disease	2197	2219	Alzheimer disease (AD)	UMLS:C0002395	Alzheimer's Disease
T68	AgeGroup	2110	2117	elderly	null	null
T34	Disease	2255	2258	DLB	UMLS:C0752347	Lewy Body Disease
T69	Phenotype	2267	2292	neuropsychiatric symptoms	UMLS:C3534763	One or more neuropsychiatric symptoms
T70	Phenotype	2297	2309	parkinsonism	HPO:HP:0001300	Parkinsonism
T71	Phenotype	2322	2342	cognitive impairment	HPO:HP:0100543	Cognitive impairment
T125	Phenotype	2360	2424	deficits of attention, executive function, and visual perception	UMLS:C1271073	Visual perceptual weakness
T73	Phenotype	2360	2424	deficits of attention, executive function, and visual perception	UMLS:C1843023	Loss of executive functions
T125	Phenotype	2360	2424	deficits of attention, executive function, and visual perception	UMLS:C1271073	Visual perceptual weakness
T77	Phenotype	2449	2469	cognitive impairment	HPO:HP:0100543	Cognitive impairment
T78	Disease	2507	2509	AD	UMLS:C0002395	Alzheimer's Disease
T35	Disease	2531	2534	DLB	UMLS:C0752347	Lewy Body Disease
T75	Phenotype	2558	2563	falls	HPO:HP:0002527	Falls
T79	Disease	2723	2725	AD	UMLS:C0002395	Alzheimer's Disease
T37	Disease	2792	2795	DLB	UMLS:C0752347	Lewy Body Disease
T80	Phenotype	2727	2774	Cholinergic neurotransmission is more defective	null	null
T81	Disease	2815	2817	AD	UMLS:C0002395	Alzheimer's Disease
T36	Disease	2855	2858	DLB	UMLS:C0752347	Lewy Body Disease
T82	Phenotype	2833	2851	cholinergic losses	UMLS:C0393947	Cholinergic crisis
T4	Drug	3200	3209	donepezil	DrugBank:DB00843	Donepezil
T38	Disease	3081	3084	DLB	UMLS:C0752347	Lewy Body Disease
T39	Disease	3214	3217	DLB	UMLS:C0752347	Lewy Body Disease
T5	Drug	3389	3398	donepezil	DrugBank:DB00843	Donepezil
T6	Drug	3335	3344	donepezil	DrugBank:DB00843	Donepezil
T7	Drug	3631	3640	donepezil	DrugBank:DB00843	Donepezil
T8	Drug	3742	3751	donepezil	DrugBank:DB00843	Donepezil
T40	Disease	3362	3365	DLB	UMLS:C0752347	Lewy Body Disease
T83	Phenotype	3456	3476	cognitive impairment	HPO:HP:0100543	Cognitive impairment
T84	Phenotype	3478	3513	behavioral and psychiatric symptoms	UMLS:C0004941	Behavioral Symptoms
T85	Phenotype	3478	3513	behavioral and psychiatric symptoms	UMLS:C0233401	Psychiatric symptom
T86	Phenotype	3515	3539	global clinical symptoms	null	null
T87	Phenotype	3763	3775	parkinsonism	HPO:HP:0001300	Parkinsonism
T88	Phenotype	3850	3870	cognitive impairment	HPO:HP:0100543	Cognitive impairment
T89	Phenotype	3875	3895	psychiatric symptoms	UMLS:C0233401	Psychiatric symptom
T9	Drug	4182	4191	donepezil	DrugBank:DB00843	Donepezil
T41	Disease	4148	4151	DLB	UMLS:C0752347	Lewy Body Disease
T10	Drug	4928	4937	donepezil	DrugBank:DB00843	Donepezil
T11	Drug	4357	4366	donepezil	DrugBank:DB00843	Donepezil
T90	Phenotype	4370	4390	cognitive impairment	HPO:HP:0100543	Cognitive impairment
T91	Measure	4423	4427	MMSE	UMLS:C0451306	Mini-mental state examination
T92	Measure	4727	4762	Neuropsychiatric Inventory-2 (NPI-2	UMLS:C3539727	Neuropsychiatric Inventory Questionnaire
T12	Drug	5157	5166	donepezil	DrugBank:DB00843	Donepezil
T42	Disease	5170	5173	DLB	UMLS:C0752347	Lewy Body Disease
T43	Disease	5206	5209	DLB	UMLS:C0752347	Lewy Body Disease
T93	Ethnicity	5341	5346	Japan	UMLS:C1556094	Japanese race
T55	Disease	5436	5470	mild to moderately severe dementia	UMLS:C3494623	Mild dementia
T94	AgeGroup	5416	5424	aged ≥50	AgeGroups:C0683973	middle aged adult (45-64 years)
T95	AgeGroup	5416	5424	aged ≥50	AgeGroups:C0001792	aged adult (elderly; 65-80 years)
T96	AgeGroup	5416	5424	aged ≥50	AgeGroups:C0001795	adult, aged over 80 (>80 years)
T97	Measure	5488	5492	MMSE	UMLS:C0451306	Mini-mental state examination
T98	ScaleMin	5472	5474	10	null	null
T99	ScaleMax	5478	5480	26	null	null
T100	Measure	5497	5521	Clinical Dementia Rating	UMLS:C0451074	Clinical dementia rating scale
T101	ScaleMax	5522	5526	≥0.5	null	null
T102	Phenotype	5532	5567	behavioral and psychiatric symptoms	UMLS:C0004941	Behavioral Symptoms
T103	Phenotype	5532	5567	behavioral and psychiatric symptoms	UMLS:C0233401	Psychiatric symptom
T90	Measure	5584	5589	NPI-2	null	null
T106	ScaleMax	5577	5579	≥8	null	null
T107	ScaleMax	5590	5593	≥ 1	null	null
T108	Measure	5596	5604	NPI-plus	UMLS:C3539727	Neuropsychiatric Inventory Questionnaire
T110	Measure	5711	5742	Cognitive Fluctuation Inventory	null	null
T111	Phenotype	5655	5687	sleep, and cognitive fluctuation	HPO:HP:0002360	Sleep disturbance
T153	Phenotype	5655	5687	sleep, and cognitive fluctuation	HPO:HP:0002360	Sleep disturbance
T93	Measure	5749	5754	NPI-2	null	null
T113	Phenotype	5768	5782	hallucinations	HPO:HP:0000738	Hallucinations
T44	Disease	6136	6139	DLB	UMLS:C0752347	Lewy Body Disease
T56	Disease	6358	6366	dementia	UMLS:C0497327	Dementia
T60	Disease	6292	6309	Parkinson disease	UMLS:C0030567	Parkinson Disease
T116	Phenotype	6421	6441	cognitive impairment	HPO:HP:0100543	Cognitive impairment
T117	Phenotype	6456	6536	infarcts/hemorrhages affecting the thalamus, caudate nucleus, or globus pallidus	null	null
T118	Phenotype	6456	6536	infarcts/hemorrhages affecting the thalamus, caudate nucleus, or globus pallidus	null	null
T119	Phenotype	6456	6536	infarcts/hemorrhages affecting the thalamus, caudate nucleus, or globus pallidus	UMLS:C1611171	Thalamic infarction
T120	Phenotype	6456	6536	infarcts/hemorrhages affecting the thalamus, caudate nucleus, or globus pallidus	UMLS:C0472376	Thalamic hemorrhage
T121	Phenotype	6456	6536	infarcts/hemorrhages affecting the thalamus, caudate nucleus, or globus pallidus	UMLS:C3472665	Hemorrhage in caudate nucleus
T122	Phenotype	6456	6536	infarcts/hemorrhages affecting the thalamus, caudate nucleus, or globus pallidus	UMLS:C3472664	Hemorrhage in globus pallidus
T123	Phenotype	6538	6552	single infarct	UMLS:C0021308	Infarction
T125	Phenotype	6620	6659	moderate or severe white matter changes	UMLS:C1833300	White matter changes
T126	Disease	6668	6702	neurologic or psychiatric diseases	UMLS:C0027765	nervous system disorder
T127	Disease	6668	6702	neurologic or psychiatric diseases	UMLS:C0004936	Mental disorders
T131	Disease	6821	6850	obstructive pulmonary disease	UMLS:C0600260	Lung Diseases, Obstructive
T133	Phenotype	6886	6897	bradycardia	HPO:HP:0001662	Bradycardia
T134	Disease	6909	6928	sick sinus syndrome	UMLS:C0037052	Sick Sinus Syndrome
T135	Disease	6930	6973	atrial or atrioventricular conduction block	UMLS:C0004245	Atrioventricular Block
T13	Phenotype	7011	7066	hypersensitivity to donepezil or piperidine derivatives	null	null
T137	Phenotype	7011	7066	hypersensitivity to donepezil or piperidine derivatives	null	null
T138	Phenotype	7068	7087	severe parkinsonism	HPO:HP:0001300	Parkinsonism
T139	Drug	7141	7146	ChEIs	UMLS:C0008425	Cholinesterase Inhibitors
T140	Drug	7154	7174	investigational drug	UMLS:C0013230	Investigational New Drugs
T61	Drug	7236	7256	anti-Parkinson drugs	UMLS:C0003405	Antiparkinson Agents
T141	Drug	7209	7214	ChEIs	UMLS:C0008425	Cholinesterase Inhibitors
T142	Drug	7216	7230	antipsychotics	UMLS:C0040615	Antipsychotic Agents
T143	Drug	7268	7274	L-dopa	DrugBank:DB01235	Levodopa
T144	Drug	7278	7295	dopamine agonists	UMLS:C0178601	Dopamine Agonists
T14	Drug	7782	7791	donepezil	DrugBank:DB00843	Donepezil
T145	Measure	9132	9136	MMSE	UMLS:C0451306	Mini-mental state examination
T146	Phenotype	9143	9178	Behavioral and psychiatric symptoms	UMLS:C0004941	Behavioral Symptoms
T147	Phenotype	9143	9178	Behavioral and psychiatric symptoms	UMLS:C0233401	Psychiatric symptom
T94	Measure	9206	9211	NPI-2	null	null
T95	Measure	9221	9227	NPI-10	null	null
T45	Disease	9375	9378	DLB	UMLS:C0752347	Lewy Body Disease
T96	Measure	9237	9242	NPI-2	null	null
T151	Phenotype	9287	9301	hallucinations	HPO:HP:0000738	Hallucinations
T153	Phenotype	10054	10079	Gastrointestinal symptoms	UMLS:C0426576	Gastrointestinal symptom
T155	Phenotype	10104	10124	psychiatric symptoms	UMLS:C0233401	Psychiatric symptom
T156	Phenotype	10130	10140	arrhythmia	HPO:HP:0011675	Arrhythmia
T15	Drug	10439	10448	donepezil	DrugBank:DB00843	Donepezil
T157	Demographic	12177	12180	USA	UMLS:C0041703	United States
T158	Gender	13106	13113	Females	Gender:C0015780	female
T159	AgeGroup	13206	13223	65 years or older	AgeGroups:C0001792	aged adult (elderly; 65-80 years)
T160	AgeGroup	13206	13223	65 years or older	AgeGroups:C0001795	adult, aged over 80 (>80 years)
T161	Measure	13322	13326	MMSE	UMLS:C0451306	Mini-mental state examination
T173	Measure	14728	14732	MMSE	UMLS:C0451306	Mini-mental state examination
T174	Measure	15201	15205	MMSE	UMLS:C0451306	Mini-mental state examination
T175	Measure	15227	15262	MMSE, Mini-Mental State Examination	UMLS:C0451306	Mini-mental state examination
T222	Measure	15574	15578	MMSE	UMLS:C0451306	Mini-mental state examination
T176	Measure	15791	15795	MMSE	UMLS:C0451306	Mini-mental state examination
T177	Measure	15830	15834	MMSE	UMLS:C0451306	Mini-mental state examination
T178	Measure	16200	16204	MMSE	UMLS:C0451306	Mini-mental state examination
T179	Measure	16461	16465	MMSE	UMLS:C0451306	Mini-mental state examination
T180	Measure	16549	16584	MMSE, Mini-Mental State Examination	UMLS:C0451306	Mini-mental state examination
T181	Measure	16751	16755	MMSE	UMLS:C0451306	Mini-mental state examination
T223	Measure	17438	17442	MMSE	UMLS:C0451306	Mini-mental state examination
T100	Measure	17766	17771	NPI-2	null	null
T102	Measure	18363	18368	NPI-2	null	null
T184	Measure	18390	18421	NPI, Neuropsychiatric Inventory	UMLS:C3539727	Neuropsychiatric Inventory Questionnaire
T103	Measure	18717	18722	NPI-2	null	null
T104	Measure	18896	18901	NPI-2	null	null
T106	Measure	18936	18941	NPI-2	null	null
T186	Measure	19404	19409	NPI-2	UMLS:C3539727	Neuropsychiatric Inventory Questionnaire
T107	Measure	19641	19646	NPI-2	null	null
T188	Measure	19730	19761	NPI, Neuropsychiatric Inventory	UMLS:C3539727	Neuropsychiatric Inventory Questionnaire
T108	Measure	19920	19925	NPI-2	null	null
T110	Measure	20160	20166	NPI-10	null	null
T191	Phenotype	21391	21399	asphyxia	UMLS:C0004044	Asphyxia
T192	Disease	21415	21424	pneumonia	UMLS:C0032285	Pneumonia
T193	Phenotype	21683	21698	nasopharyngitis	UMLS:C0027441	Nasopharyngitis
T194	Phenotype	21722	21734	parkinsonism	HPO:HP:0001300	Parkinsonism
T195	Phenotype	21810	21822	parkinsonism	HPO:HP:0001300	Parkinsonism
T196	Phenotype	21917	21925	insomnia	HPO:HP:0100785	Insomnia
T197	Phenotype	21927	21948	visual hallucinations	HPO:HP:0002367	Visual hallucinations
T198	Phenotype	21950	21962	irritability	HPO:HP:0000737	Irritability
T199	Phenotype	21964	21973	agitation	HPO:HP:0000713	Agitation
T200	Phenotype	21979	21987	paranoia	HPO:HP:0011999	Paranoia
T217	Phenotype	23806	23814	diarrhea	HPO:HP:0002014	Diarrhea
T218	Phenotype	23816	23834	decreased appetite	HPO:HP:0004396	Poor appetite
T219	Phenotype	23858	23870	constipation	HPO:HP:0002019	Constipation
T220	Phenotype	23876	23882	nausea	HPO:HP:0002018	Nausea
T221	Phenotype	23942	23947	ileus	HPO:HP:0002595	Ileus
T235	Phenotype	24089	24101	Constipation	HPO:HP:0002019	Constipation
T236	Phenotype	24103	24111	diarrhea	HPO:HP:0002014	Diarrhea
T237	Phenotype	24135	24155	abdominal pain upper	UMLS:C0232492	Upper abdominal pain
T238	Phenotype	24157	24166	dyspepsia	UMLS:C0013395	Dyspepsia
T239	Phenotype	24168	24177	gastritis	HPO:HP:0005263	Gastritis
T240	Phenotype	24179	24185	nausea	HPO:HP:0002018	Nausea
T241	Phenotype	24191	24209	decreased appetite	HPO:HP:0004396	Poor appetite
T273	Phenotype	25777	25798	Parkinsonian symptoms	HPO:HP:0001300	Parkinsonism
T274	Phenotype	25857	25869	parkinsonism	HPO:HP:0001300	Parkinsonism
T275	Phenotype	25893	25905	camptocormia	HPO:HP:0100595	Camptocormia
T276	Phenotype	25990	26002	parkinsonism	HPO:HP:0001300	Parkinsonism
T277	Phenotype	26021	26029	akinesia	HPO:HP:0002304	Akinesia
T278	Phenotype	26035	26041	tremor	HPO:HP:0001337	Tremor
T279	Phenotype	26100	26121	parkinsonian symptoms	HPO:HP:0001300	Parkinsonism
T287	Phenotype	28264	28272	insomnia	HPO:HP:0100785	Insomnia
T289	Phenotype	28361	28382	visual hallucinations	HPO:HP:0002367	Visual hallucinations
T290	Phenotype	28387	28395	insomnia	HPO:HP:0100785	Insomnia
T291	Phenotype	28400	28408	paranoia	HPO:HP:0011999	Paranoia
T292	Phenotype	28413	28422	agitation	HPO:HP:0000713	Agitation
T293	Phenotype	28424	28436	irritability	HPO:HP:0000737	Irritability
T294	Phenotype	28442	28456	hallucinations	HPO:HP:0000738	Hallucinations
T317	Phenotype	29763	29784	loss of consciousness	HPO:HP:0007185	Loss of consciousness
T318	Phenotype	29923	29944	loss of consciousness	HPO:HP:0007185	Loss of consciousness
T326	Phenotype	30697	30756	Excessive decrease of systolic and diastolic blood pressure	UMLS:C0277885	Decreased systolic arterial pressure
T327	Phenotype	30697	30756	Excessive decrease of systolic and diastolic blood pressure	UMLS:C0277890	Decreased diastolic arterial pressure
T329	Phenotype	30922	30951	Abnormal change in pulse rate	UMLS:C0277901	Abnormal pulse rate
T330	Phenotype	31031	31051	Weight was decreased	HPO:HP:0001824	Weight loss
T224	Measure	31273	31277	MMSE	UMLS:C0451306	Mini-mental state examination
T16	Drug	31389	31398	donepezil	DrugBank:DB00843	Donepezil
T17	Drug	31485	31494	donepezil	DrugBank:DB00843	Donepezil
T46	Disease	31565	31568	DLB	UMLS:C0752347	Lewy Body Disease
T331	Phenotype	31461	31481	cognitive impairment	HPO:HP:0100543	Cognitive impairment
T18	Drug	31606	31615	donepezil	DrugBank:DB00843	Donepezil
T225	Measure	31673	31677	MMSE	UMLS:C0451306	Mini-mental state examination
T332	Disease	31633	31652	mild to moderate AD	UMLS:C0002395	Alzheimer's Disease
T19	Drug	31975	31984	donepezil	DrugBank:DB00843	Donepezil
T47	Disease	32011	32014	DLB	UMLS:C0752347	Lewy Body Disease
T48	Disease	31890	31893	DLB	UMLS:C0752347	Lewy Body Disease
T333	Phenotype	31866	31886	cognitive impairment	HPO:HP:0100543	Cognitive impairment
T334	Disease	31902	31904	AD	UMLS:C0002395	Alzheimer's Disease
T335	Disease	32038	32040	AD	UMLS:C0002395	Alzheimer's Disease
T336	Phenotype	32181	32201	cognitive impairment	HPO:HP:0100543	Cognitive impairment
T20	Drug	32272	32281	donepezil	DrugBank:DB00843	Donepezil
T111	Measure	32334	32339	NPI-2	null	null
T112	Measure	32344	32350	NPI-10	null	null
T337	Phenotype	32235	32270	behavioral and psychiatric symptoms	UMLS:C0004941	Behavioral Symptoms
T338	Phenotype	32235	32270	behavioral and psychiatric symptoms	UMLS:C0233401	Psychiatric symptom
T339	Phenotype	32684	32719	behavioral and psychiatric symptoms	UMLS:C0004941	Behavioral Symptoms
T340	Phenotype	32684	32719	behavioral and psychiatric symptoms	UMLS:C0233401	Psychiatric symptom
T21	Drug	32840	32849	donepezil	DrugBank:DB00843	Donepezil
T226	Measure	33106	33110	MMSE	UMLS:C0451306	Mini-mental state examination
T227	Measure	33175	33179	MMSE	UMLS:C0451306	Mini-mental state examination
T114	Measure	33123	33128	NPI-2	null	null
T113	Measure	33210	33215	NPI-2	null	null
T228	Measure	33699	33703	MMSE	UMLS:C0451306	Mini-mental state examination
T341	Phenotype	34210	34222	parkinsonism	HPO:HP:0001300	Parkinsonism
T342	Phenotype	34420	34476	gastrointestinal, psychiatric, and parkinsonian symptoms	UMLS:C0233401	Psychiatric symptom
T343	Phenotype	34420	34476	gastrointestinal, psychiatric, and parkinsonian symptoms	UMLS:HP:0001300	Parkinsonism
T344	Phenotype	34420	34476	gastrointestinal, psychiatric, and parkinsonian symptoms	UMLS:C0426576	Gastrointestinal symptom
T345	Drug	34653	34658	ChEIs	UMLS:C0008425	Cholinesterase Inhibitors
T22	Drug	34747	34756	donepezil	DrugBank:DB00843	Donepezil
T49	Disease	34932	34935	DLB	UMLS:C0752347	Lewy Body Disease
T346	Disease	34781	34783	AD	UMLS:C0002395	Alzheimer's Disease
T347	Phenotype	34798	34806	diarrhea	HPO:HP:0002014	Diarrhea
T348	Phenotype	34816	34822	nausea	HPO:HP:0002018	Nausea
T349	Phenotype	34836	34844	vomiting	HPO:HP:0002013	Vomiting
T350	Phenotype	35312	35337	gastrointestinal symptoms	HPO:C0426576	Gastrointestinal symptom
T23	Drug	35387	35396	donepezil	DrugBank:DB00843	Donepezil
T50	Disease	35473	35476	DLB	UMLS:C0752347	Lewy Body Disease
T351	Phenotype	35373	35385	parkinsonism	HPO:HP:0001300	Parkinsonism
T352	Phenotype	35422	35445	extrapyramidal symptoms	UMLS:C0234133	Extrapyramidal sign
T353	Phenotype	35494	35506	parkinsonism	HPO:HP:0001300	Parkinsonism
T354	Phenotype	35556	35577	parkinsonian symptoms	HPO:HP:0001300	Parkinsonism
T355	Phenotype	36019	36040	loss of consciousness	HPO:HP:0007185	Loss of consciousness
T24	Drug	36542	36551	donepezil	DrugBank:DB00843	Donepezil
T25	Drug	36591	36600	donepezil	DrugBank:DB00843	Donepezil
T356	Phenotype	36369	36390	loss of consciousness	HPO:HP:0007185	Loss of consciousness
T26	Drug	36951	36960	donepezil	DrugBank:DB00843	Donepezil
T358	Phenotype	37091	37103	parkinsonism	HPO:HP:0001300	Parkinsonism
T359	Phenotype	37108	37147	gastrointestinal or arrhythmic symptoms	UMLS:C0426576	Gastrointestinal symptom
T360	Phenotype	37108	37147	gastrointestinal or arrhythmic symptoms	null	null
T51	Disease	37501	37504	DLB	UMLS:C0752347	Lewy Body Disease
T27	Drug	37611	37620	donepezil	DrugBank:DB00843	Donepezil
T28	Drug	37715	37724	donepezil	DrugBank:DB00843	Donepezil
T52	Disease	37811	37814	DLB	UMLS:C0752347	Lewy Body Disease
T361	Phenotype	37747	37774	impaired cognitive function	HPO:HP:0100543	Cognitive impairment
R1	hasScale	5488	5492	Measure	5472	5474	ScaleMin
R2	hasScale	5488	5492	Measure	5478	5480	ScaleMax
R3	hasScale	5497	5521	Measure	5522	5526	ScaleMax
R4	hasScale	5568	5576	Measure	5577	5579	ScaleMax
R5	hasScale	5584	5589	Measure	5590	5593	ScaleMax
